메뉴 건너뛰기




Volumn 64, Issue 6, 2014, Pages 845-847

Surrogate outcomes for ESRD risk: The Case for a 30% reduction in estimated GFR over 2 years

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE;

EID: 84910629666     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2014.08.009     Document Type: Editorial
Times cited : (3)

References (27)
  • 1
    • 67650451498 scopus 로고    scopus 로고
    • Proteinuria as a surrogate outcome in CKD: Report of a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration
    • A.S. Levey, D. Cattran, and A. Friedman Proteinuria as a surrogate outcome in CKD: report of a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration Am J Kidney Dis 54 2 2009 205 226
    • (2009) Am J Kidney Dis , vol.54 , Issue.2 , pp. 205-226
    • Levey, A.S.1    Cattran, D.2    Friedman, A.3
  • 2
    • 84903276794 scopus 로고    scopus 로고
    • Early change in proteinuria as a surrogate end point for kidney disease progression: An individual patient meta-analysis
    • L.A. Inker, A.S. Levey, K. Pandya, N. Stoycheff, A. Okparavero, and T. Greene Early change in proteinuria as a surrogate end point for kidney disease progression: an individual patient meta-analysis Am J Kidney Dis 64 1 2014 74 85
    • (2014) Am J Kidney Dis , vol.64 , Issue.1 , pp. 74-85
    • Inker, L.A.1    Levey, A.S.2    Pandya, K.3    Stoycheff, N.4    Okparavero, A.5    Greene, T.6
  • 3
    • 84902826499 scopus 로고    scopus 로고
    • Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality
    • J. Coresh, T.C. Turin, and K. Matsushita Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality JAMA 311 24 2014 2518 2531
    • (2014) JAMA , vol.311 , Issue.24 , pp. 2518-2531
    • Coresh, J.1    Turin, T.C.2    Matsushita, K.3
  • 4
    • 84892925764 scopus 로고    scopus 로고
    • Estimated GFR decline as a surrogate end point for kidney failure: A post hoc analysis from the Reduction of End Points in Non-Insulin-Dependent Diabetes with the Angiotensin II Antagonist Losartan (RENAAL) Study and Irbesartan Diabetic Nephropathy Trial
    • H.J. Lambers Heerspink, M. Weldegiorgis, and L.A. Inker Estimated GFR decline as a surrogate end point for kidney failure: a post hoc analysis from the Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan (RENAAL) Study and Irbesartan Diabetic Nephropathy Trial Am J Kidney Dis 63 2 2014 244 250
    • (2014) Am J Kidney Dis , vol.63 , Issue.2 , pp. 244-250
    • Lambers Heerspink, H.J.1    Weldegiorgis, M.2    Inker, L.A.3
  • 5
    • 34249702586 scopus 로고    scopus 로고
    • Surrogate end points for clinical trials of kidney disease progression
    • L.A. Stevens, T. Greene, and A.S. Levey Surrogate end points for clinical trials of kidney disease progression Clin J Am Soc Nephrol 1 4 2006 874 884
    • (2006) Clin J Am Soc Nephrol , vol.1 , Issue.4 , pp. 874-884
    • Stevens, L.A.1    Greene, T.2    Levey, A.S.3
  • 6
    • 0024520844 scopus 로고
    • Surrogate endpoints in clinical trials: Definition and operational criteria
    • R.L. Prentice Surrogate endpoints in clinical trials: definition and operational criteria Stat Med 8 4 1989 431 440
    • (1989) Stat Med , vol.8 , Issue.4 , pp. 431-440
    • Prentice, R.L.1
  • 7
    • 0033603794 scopus 로고    scopus 로고
    • Users' guides to the medical literature: XIX. Applying clinical trial results. A. How to use an article measuring the effect of an intervention on surrogate end points. Evidence-Based Medicine Working Group
    • H.C. Bucher, G.H. Guyatt, D.J. Cook, A. Holbrook, and F.A. McAlister Users' guides to the medical literature: XIX. Applying clinical trial results. A. How to use an article measuring the effect of an intervention on surrogate end points. Evidence-Based Medicine Working Group JAMA 282 8 1999 771 778
    • (1999) JAMA , vol.282 , Issue.8 , pp. 771-778
    • Bucher, H.C.1    Guyatt, G.H.2    Cook, D.J.3    Holbrook, A.4    McAlister, F.A.5
  • 9
    • 72049117391 scopus 로고    scopus 로고
    • Rapid decline of kidney function increases cardiovascular risk in the elderly
    • M.G. Shlipak, R. Katz, and B. Kestenbaum Rapid decline of kidney function increases cardiovascular risk in the elderly J Am Soc Nephrol 20 12 2009 2625 2630
    • (2009) J Am Soc Nephrol , vol.20 , Issue.12 , pp. 2625-2630
    • Shlipak, M.G.1    Katz, R.2    Kestenbaum, B.3
  • 10
    • 84868556470 scopus 로고    scopus 로고
    • Short-term change in kidney function and risk of end-stage renal disease
    • T.C. Turin, J. Coresh, and M. Tonelli Short-term change in kidney function and risk of end-stage renal disease Nephrol Dial Transplant 27 10 2012 3835 3843
    • (2012) Nephrol Dial Transplant , vol.27 , Issue.10 , pp. 3835-3843
    • Turin, T.C.1    Coresh, J.2    Tonelli, M.3
  • 11
    • 84862173307 scopus 로고    scopus 로고
    • One-year change in kidney function is associated with an increased mortality risk
    • T.C. Turin, J. Coresh, and M. Tonelli One-year change in kidney function is associated with an increased mortality risk Am J Nephrol 36 1 2012 41 49
    • (2012) Am J Nephrol , vol.36 , Issue.1 , pp. 41-49
    • Turin, T.C.1    Coresh, J.2    Tonelli, M.3
  • 12
    • 84875709047 scopus 로고    scopus 로고
    • Change in the estimated glomerular filtration rate over time and risk of all-cause mortality
    • T.C. Turin, J. Coresh, and M. Tonelli Change in the estimated glomerular filtration rate over time and risk of all-cause mortality Kidney Int 83 4 2013 684 691
    • (2013) Kidney Int , vol.83 , Issue.4 , pp. 684-691
    • Turin, T.C.1    Coresh, J.2    Tonelli, M.3
  • 13
    • 55949102694 scopus 로고    scopus 로고
    • Rapid kidney function decline and mortality risk in older adults
    • D.E. Rifkin, M.G. Shlipak, and R. Katz Rapid kidney function decline and mortality risk in older adults Arch Intern Med 168 20 2008 2212 2218
    • (2008) Arch Intern Med , vol.168 , Issue.20 , pp. 2212-2218
    • Rifkin, D.E.1    Shlipak, M.G.2    Katz, R.3
  • 15
    • 78149302507 scopus 로고    scopus 로고
    • Rate of kidney function decline associates with mortality
    • Z. Al-Aly, A. Zeringue, and J. Fu Rate of kidney function decline associates with mortality J Am Soc Nephrol 21 11 2010 1961 1969
    • (2010) J Am Soc Nephrol , vol.21 , Issue.11 , pp. 1961-1969
    • Al-Aly, Z.1    Zeringue, A.2    Fu, J.3
  • 16
    • 84869223202 scopus 로고    scopus 로고
    • Greater variability in kidney function is associated with an increased risk of death
    • Z. Al-Aly, S. Balasubramanian, J.R. McDonald, J.F. Scherrer, and A.M. O'Hare Greater variability in kidney function is associated with an increased risk of death Kidney Int 82 11 2012 1208 1214
    • (2012) Kidney Int , vol.82 , Issue.11 , pp. 1208-1214
    • Al-Aly, Z.1    Balasubramanian, S.2    McDonald, J.R.3    Scherrer, J.F.4    O'Hare, A.M.5
  • 17
    • 84865202588 scopus 로고    scopus 로고
    • The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of end-stage renal disease
    • J. Skupien, J.H. Warram, and A.M. Smiles The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of end-stage renal disease Kidney Int 82 5 2012 589 597
    • (2012) Kidney Int , vol.82 , Issue.5 , pp. 589-597
    • Skupien, J.1    Warram, J.H.2    Smiles, A.M.3
  • 20
    • 84902785403 scopus 로고    scopus 로고
    • Validity and statistical power of alternative eGFR-based endpoints: A report from an NFK FDA Workshop
    • [abstract]
    • T.H. Greene, C.-C. Teng, and A.M. Redd Validity and statistical power of alternative eGFR-based endpoints: a report from an NFK FDA Workshop [abstract] J Am Soc Nephrol 24 2013 151A
    • (2013) J Am Soc Nephrol , vol.24 , pp. 151A
    • Greene, T.H.1    Teng, C.-C.2    Redd, A.M.3
  • 21
    • 84862777509 scopus 로고    scopus 로고
    • Trajectories of kidney function decline in the 2 years before initiation of long-term dialysis
    • A.M. O'Hare, A. Batten, and N.R. Burrows Trajectories of kidney function decline in the 2 years before initiation of long-term dialysis Am J Kidney Dis 59 4 2012 513 522
    • (2012) Am J Kidney Dis , vol.59 , Issue.4 , pp. 513-522
    • O'Hare, A.M.1    Batten, A.2    Burrows, N.R.3
  • 22
    • 84864397514 scopus 로고    scopus 로고
    • CKD progression: A risky business
    • A. Chang, and H. Kramer CKD progression: a risky business Nephrol Dial Transplant 27 7 2012 2607 2609
    • (2012) Nephrol Dial Transplant , vol.27 , Issue.7 , pp. 2607-2609
    • Chang, A.1    Kramer, H.2
  • 23
    • 84859879072 scopus 로고    scopus 로고
    • Improvement in kidney function: A real occurrence
    • T.C. Turin, and B.R. Hemmelgarn Improvement in kidney function: a real occurrence J Am Soc Nephrol 23 4 2012 575 577
    • (2012) J Am Soc Nephrol , vol.23 , Issue.4 , pp. 575-577
    • Turin, T.C.1    Hemmelgarn, B.R.2
  • 24
    • 84870602492 scopus 로고    scopus 로고
    • Variability in estimated glomerular filtration rate is an independent risk factor for death among patients with stage 3 chronic kidney disease
    • R.M. Perkins, X. Tang, A.C. Bengier, H.L. Kirchner, and I.D. Bucaloiu Variability in estimated glomerular filtration rate is an independent risk factor for death among patients with stage 3 chronic kidney disease Kidney Int 82 12 2012 1332 1338
    • (2012) Kidney Int , vol.82 , Issue.12 , pp. 1332-1338
    • Perkins, R.M.1    Tang, X.2    Bengier, A.C.3    Kirchner, H.L.4    Bucaloiu, I.D.5
  • 25
    • 84859808611 scopus 로고    scopus 로고
    • Kidney function can improve in patients with hypertensive CKD
    • B. Hu, C. Gadegbeku, and M.S. Lipkowitz Kidney function can improve in patients with hypertensive CKD J Am Soc Nephrol 23 4 2012 706 713
    • (2012) J Am Soc Nephrol , vol.23 , Issue.4 , pp. 706-713
    • Hu, B.1    Gadegbeku, C.2    Lipkowitz, M.S.3
  • 26
    • 76749156220 scopus 로고    scopus 로고
    • Predictors of declining glomerular filtration rate in a population-based chronic kidney disease cohort
    • B.O. Eriksen, J. Tomtum, and O.C. Ingebretsen Predictors of declining glomerular filtration rate in a population-based chronic kidney disease cohort Nephron Clin Pract 115 1 2010 c41 c50
    • (2010) Nephron Clin Pract , vol.115 , Issue.1 , pp. 41-c50
    • Eriksen, B.O.1    Tomtum, J.2    Ingebretsen, O.C.3
  • 27
    • 0026011647 scopus 로고
    • Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial
    • D.S. Echt, P.R. Liebson, and L.B. Mitchell Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial N Engl J Med 324 12 1991 781 788
    • (1991) N Engl J Med , vol.324 , Issue.12 , pp. 781-788
    • Echt, D.S.1    Liebson, P.R.2    Mitchell, L.B.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.